Coronavirus: Johnson & Johnson one-shot vaccine generates lasting response, interim results show

Johnson & Johnson’s experimental one-shot Covid-19 vaccine generated a long-lasting immune response in an early safety study, providing a glimpse at how it will perform in the real world as the company inches closer to approaching US regulators for clearance.More than 90 per cent of participants made immune proteins, called neutralising antibodies, within 29 days after receiving the shot, according to the report, and participants formed the antibodies within 57 days. The immune response lasted… …read more

Source:: SCMP – United States & Canada

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *